HF
RIGL icon

HRT Financial’s Rigel Pharmaceuticals RIGL Stock Holding History

HRT Financial’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-68,191
Closed -$1.15M – 3259
2024
Q4 		$1.15M Buy
+68,191
New +$1.31M 0.01% 1007
2024
Q3 		– Sell
-27,687
Closed -$227K – 3022
2024
Q2 		$227K Buy
+27,687
New +$290K ﹤0.01% 1607
2023
Q3 		– Sell
-1,485
Closed -$19K – 2981
2023
Q2 		$19K Sell
1,485
-558
-27% -$7.54K ﹤0.01% 2104
2023
Q1 		$26K Sell
2,043
-16,093
-89% -$256K ﹤0.01% 2166
2022
Q4 		$272K Sell
18,136
-90,228
-83% -$827K ﹤0.01% 1779
2022
Q3 		$1.28M Buy
+108,364
New +$1.47M 0.01% 783
2022
Q2 		– Sell
-13,867
Closed -$414K – 3600
2022
Q1 		$414K Sell
13,867
-1,071
-7% -$29K ﹤0.01% 1985
2021
Q4 		$395K Sell
14,938
-3,144
-17% -$94.9K ﹤0.01% 2079
2021
Q3 		$656K Buy
18,082
+16,771
+1,279% +$660K ﹤0.01% 1752
2021
Q2 		$56K Sell
1,311
-1,459
-53% -$55.1K ﹤0.01% 2672
2021
Q1 		$94K Sell
2,770
-2,879
-51% -$114K ﹤0.01% 2469
2020
Q4 		$197K Buy
+5,649
New +$164K ﹤0.01% 1498
2020
Q1 		– Sell
-1,104
Closed -$23K – 1260
2019
Q4 		$23K Buy
+1,104
New +$22.7K ﹤0.01% 1089
2019
Q1 		– Sell
-1,221
Closed -$28K – 742
2018
Q4 		$28K Buy
+1,221
New +$34.5K ﹤0.01% 548

Other funds holding RIGL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CLGM
Capitolis Liquid Global Markets New York $15.7B AUM 30.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HRT Financial's RIGL Position: Q1 2025 in Review

HRT Financial sold out of Rigel Pharmaceuticals (RIGL) in Q1 2025, closing a stake of 68,191 shares — an estimated $1.15M sold.

HRT Financial first reported a position in RIGL in Q4 2018 and held it in 14 quarters. The position peaked at $1.28M in Q3 2022. 123 funds tracked by Wall St. Rank hold RIGL as of Q1 2025.

  • HRT Financial reported no remaining Rigel Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • HRT Financial sold 68,191 Rigel Pharmaceuticals shares in Q1 2025, an estimated $1.15M.
  • HRT Financial first reported a position in Rigel Pharmaceuticals in Q4 2018 and held it in 14 quarters.
  • HRT Financial's Rigel Pharmaceuticals position peaked at $1.28M in Q3 2022.
  • 123 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q1 2025.

Based on HRT Financial's 13F filing for Q1 2025, filed 15 May 2025.